BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29991717)

  • 1. miR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via PAI-1-Sox2 axis.
    Zhang Y; Pan Y; Xie C; Zhang Y
    Cell Death Dis; 2018 Jul; 9(7):777. PubMed ID: 29991717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma.
    Deng Y; Zhao F; Zhang Z; Sun F; Wang M
    Cancer Biother Radiopharm; 2018 Nov; 33(9):365-372. PubMed ID: 29989838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer.
    Lin X; Lin BW; Chen XL; Zhang BL; Xiao XJ; Shi JS; Lin JD; Chen X
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1464-1470. PubMed ID: 28988111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-126 functions as a tumor suppressor in osteosarcoma by targeting Sox2.
    Yang C; Hou C; Zhang H; Wang D; Ma Y; Zhang Y; Xu X; Bi Z; Geng S
    Int J Mol Sci; 2013 Dec; 15(1):423-37. PubMed ID: 24384842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene.
    Pu Y; Zhao F; Wang H; Cai S
    Sci Rep; 2017 Mar; 7():44218. PubMed ID: 28281638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks.
    Yang Z; Liu T; Ren X; Yang M; Tu C; Li Z
    Cell Cycle; 2022 Oct; 21(20):2121-2131. PubMed ID: 35699451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-34a is downregulated in human osteosarcoma stem-like cells and promotes invasion, tumorigenic ability and self-renewal capacity.
    Zou Y; Huang Y; Yang J; Wu J; Luo C
    Mol Med Rep; 2017 Apr; 15(4):1631-1637. PubMed ID: 28260055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene.
    Pu Y; Zhao F; Li Y; Cui M; Wang H; Meng X; Cai S
    BMC Cancer; 2017 Jan; 17(1):45. PubMed ID: 28073349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-210 is increased and it is required for dedifferentiation of osteosarcoma cell line.
    Zhang H; Mai Q; Chen J
    Cell Biol Int; 2017 Mar; 41(3):267-275. PubMed ID: 28032372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene.
    Pu Y; Zhao F; Wang H; Cai W; Gao J; Li Y; Cai S
    Oncotarget; 2016 May; 7(19):28420-34. PubMed ID: 27056900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-1 as regulator of tumor-initiating cell properties in head and neck cancers.
    Lee YC; Yu CC; Lan C; Lee CH; Lee HT; Kuo YL; Wang PH; Chang WW
    Head Neck; 2016 Apr; 38 Suppl 1():E895-904. PubMed ID: 25974262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal.
    Li QC; Xu H; Wang X; Wang T; Wu J
    Cancer Biomark; 2017 Dec; 21(1):135-144. PubMed ID: 29060932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.
    Vetter NS; Kolb EA; Mills CC; Sampson VB
    Mol Cancer Res; 2017 Jul; 15(7):953-964. PubMed ID: 28275089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-34a inhibits tumor invasion and metastasis in osteosarcoma partly by effecting C-IAP2 and Bcl-2.
    Wen J; Zhao YK; Liu Y; Zhao JF
    Tumour Biol; 2017 Jun; 39(6):1010428317705761. PubMed ID: 28635396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of miR-1258 inhibits cell proliferation by targeting AKT3 in osteosarcoma.
    Liu W; Zhou Z; Zhang Q; Rong Y; Li L; Luo Y; Wang J; Yin G; Lv C; Cai W
    Biochem Biophys Res Commun; 2019 Mar; 510(3):479-486. PubMed ID: 30737029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-205 functions as a tumor suppressor via targeting TGF-α in osteosarcoma.
    Yang G; Zhang P; Lv A; Liu Y; Wang G
    Exp Mol Pathol; 2016 Feb; 100(1):160-6. PubMed ID: 26708425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.
    Ji Q; Xu X; Li L; Goodman SB; Bi W; Xu M; Xu Y; Fan Z; Maloney WJ; Ye Q; Wang Y
    Cell Death Dis; 2017 Oct; 8(10):e3103. PubMed ID: 29022909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-17 promotes osteosarcoma cells proliferation and migration and inhibits apoptosis by regulating SASH1 expression.
    Wu D; Zhang H; Ji F; Ding W
    Pathol Res Pract; 2019 Jan; 215(1):115-120. PubMed ID: 30396754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.